Crucell N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 08 apr 2008 - 13:59

Statutaire naam Crucell N.V.

Titel Crucell Announces STAR® Research License Agreement with Celltrion, Inc.

Bericht Leiden, The Netherlands, 8 April 2008 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STAR® research license agreement with Celltrion, Inc. for the production of recombinant proteins. Under the agreement, Celltrion will evaluate Crucell’s STAR® technology for generating cell lines for the manufacture of biopharmaceuticals. Financial details of the agreement were not disclosed.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

200804080000000014_License agreement Celltrion_FINAL.pdf (opens in a new window)

Datum laatste update: 20 maart 2025